Overview

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB

Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-20
Target enrollment:
Participant gender:
Summary
International multicenter, investigator-driven, open-label, randomized (1:1) clinical trial to observe and evaluate the rate of ischemic and bleeding adverse events of a single antiplatelet regimen (SAPT) since the time of PCI with latest generation DCB in elderly or HBR population with stable or unstable coronary syndromes.
Phase:
NA
Details
Lead Sponsor:
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Collaborator:
Fundación EPIC